# A Study of AMDX-2011P in Participants With CAA

> **NCT05709314** · PHASE2 · RECRUITING · sponsor: **Amydis Inc.** · enrollment: 25 (estimated)

## Conditions studied

- Cerebral Amyloid Angiopathy

## Interventions

- **DRUG:** AMDX-2011P

## Key facts

- **NCT ID:** NCT05709314
- **Lead sponsor:** Amydis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709314, "A Study of AMDX-2011P in Participants With CAA". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05709314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*